Mouse models of PIK3CA mutations: one mutation initiates heterogeneous mammary tumors
- 1 March 2013
- journal article
- review article
- Published by Wiley in The FEBS Journal
- Vol. 280 (12) , 2758-2765
Abstract
The phosphoinositide 3‐kinase (PI3K) signaling pathway is crucial for cell growth, proliferation, metabolism, and survival, and is frequently deregulated in human cancer, including ~ 70% of breast tumors. PIK3CA, the gene encoding the catalytic subunit p110α of PI3K, is mutated in ~ 30% of breast cancers. However, the exact mechanism of PIK3CA‐evoked breast tumorigenesis has not yet been defined. Genetically engineered mouse models are valuable for examining the initiation, development and progression of cancer. Transgenic mice harboring hotspot mutations in p110α have helped to elucidate breast cancer pathogenesis and increase our knowledge about molecular and cellular alterations in vivo. They are also useful for the development of therapeutic strategies. Here, we describe current mouse models of mutant PIK3CA in the mammary gland, and discuss differences in tumor latency and pathogenesis.Keywords
This publication has 55 references indexed in Scilit:
- Conditional activation of Pik3caH1047R in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutationsOncogene, 2012
- Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway–dependent and PI3K pathway–independent mechanismsNature Medicine, 2011
- Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypesBreast Cancer Research and Treatment, 2011
- PTEN loss in the continuum of common cancers, rare syndromes and mouse modelsNature Reviews Cancer, 2011
- PIK3CA Mutations in In situ and Invasive Breast CarcinomasCancer Research, 2010
- Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancersNature Medicine, 2008
- PI3K pathway alterations in cancer: variations on a themeOncogene, 2008
- Class I PI3K in oncogenic cellular transformationOncogene, 2008
- Genetic cooperation between p21Cip1 and INK4 inhibitors in cellular senescence and tumor suppressionOncogene, 2007
- PIK3CA Mutations Correlate with Hormone Receptors, Node Metastasis, and ERBB2, and Are Mutually Exclusive with PTEN Loss in Human Breast CarcinomaCancer Research, 2005